{"schema_version":"secwatch.filing_event.v1","accession":"0000937556-25-000106","form_type":"8-K","ticker":"MASI","cik":"0000937556","company_name":"MASIMO CORP","filed_at":"2025-08-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.742433+00:00","generated_at":"2026-05-17T21:18:26.849034+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Masimo Q2 revenue $371M (+8% YoY); Non-GAAP EPS $1.33 (+46%); tariff impact halved","bullets":["GAAP revenue $371M (+8% YoY); GAAP diluted EPS $0.82; Non-GAAP diluted EPS $1.33 (+46%).","Non-GAAP revenue $370M (+7% constant currency); core healthcare business driving growth.","Updated FY2025 non-GAAP revenue guidance $1,505-1,535M (8-11% constant currency growth).","Tariff mitigation effective: new guidance including tariffs reduces operating margin to 27.0-27.5% vs 28.3-28.7% ex-tariffs.","CEO highlights expansion of leadership team and tariff mitigation measures reducing impact by 50%."],"urls":{"canonical":"https://secwatch.observer/filing/0000937556-25-000106","json":"https://secwatch.observer/filing/0000937556-25-000106.json","markdown":"https://secwatch.observer/filing/0000937556-25-000106.md","text":"https://secwatch.observer/filing/0000937556-25-000106.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/937556/000093755625000106/0000937556-25-000106-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/937556/000093755625000106/masi-20250805.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T21:18:26.849034+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}